Eyelash Trichomegaly Secondary to Panitumumab Therapy
نویسندگان
چکیده
منابع مشابه
Eyelash Trichomegaly: A Rare Presenting Feature of Systemic Lupus Erythematosus
An increase in length, curling, pigmentation, or thickness of eyelashes is termed eyelash trichomegaly. It may be inherited as an isolated trait or as a feature of a congenital syndrome such as Oliver-McFarlane syndrome or oculocutaneous albinism. Acquired conditions associated with eyelash trichomegaly include HIV infection, connective tissue disorders, and the administration of drugs such as ...
متن کاملEpistaxis secondary to panitumumab in a patient with colon cancer.
Epidermal growth factor receptor inhibitors (EGFRIs) have become an integral part of therapy for many types of solid malignancy, including colorectal cancer. The drug class has proven to be effective without causing many of the side-effects associated with chemotherapy or other growth factor receptor inhibitors. Epistaxis, a common side-effect of Vascular Endothelial Growth Factor inhibitors, i...
متن کاملEyelashes Trichomegaly: An Unusual Side Effect of Gefitinib Therapy
Evolution of targeted therapy has changed the spectrum of treatment in oncology since the past two decades as lots of newer agents are being added to the pharmacologic armamentarium of cancer therapy. Epidermal growth factor receptor inhibitors form one such advancing field with many newer agents being investigated and they are used in wide variety of malignancies such as head and neck cancer, ...
متن کاملEyelash formation secondary to latanoprost treatment in a patient with alopecia.
Eyelashes have a protective function against airborne particles. In addition, loss of eyelashes can be cosmetically unacceptable to some patients. For eyelash loss due to alopecia, treatments including oral steroids or other systemic medications have limited efficacy and can be potentially dangerous to the eye. We report growth of eyelashes after treatment with latanoprost in a patient with tot...
متن کاملTrichomegaly and scalp hair changes following treatment with erlotinib in pulmonary adenocarcinoma patients: A case report and literature review
Erlotinib is among the oral EGFR-tyrosine kinase inhibitors used to treat non-small cell lung cancer. The common side effects of erlotinib include acne form rash and diarrhea. Eyelash trichomegaly and alterations of scalp hair are rarely observed symptoms. In the present study, we report changes in eyelash trichomegaly and scalp hair in six cases of pulmonary adenocarcinoma patients that had be...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Oncology
سال: 2011
ISSN: 1718-7729
DOI: 10.3747/co.v18i3.762